Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Purohit

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Archives of General Psychiatry|November 24, 1999
Neuropeptide abnormalities in patients with early Alzheimer diseaseK L Davis, R C Mohs, D B Marin, et al.
Biological Psychiatry|February 15, 1993
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological studyD P Purohit, M Davidson, D P Perl, et al.
Schizophrenia Research|May 1, 1994
Cortical cholinergic markers in schizophreniaV Haroutunian, M Davidson, P D Kanof, et al.
Neurology|September 4, 2008
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathologyM S Beeri, J Schmeidler, J M Silverman, et al.
International Journal of Alzheimer'S Disease|July 14, 2012
Characterizing cognitive deficits and dementia in an aging urban population in IndiaG Nair, K Van Dyk, U Shah, et al.
Journal of Neurochemistry|February 1, 1995
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficitsL M Bierer, V Haroutunian, S Gabriel, et al.
Archives of Neurology|December 26, 2001
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive declineS Parvathy, P Davies, V Haroutunian, et al.
Acta Neuropathologica|January 1, 1994
Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disordersP R Hof, E A Nimchinsky, V Buée-Scherrer, et al.
Psychiatry Research|December 1, 1993
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptomsL M Bierer, P J Knott, J M Schmeidler, et al.
Neurology|May 10, 2006
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriersM S Beeri, M Rapp, J M Silverman, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Archives of General Psychiatry|November 24, 1999
Neuropeptide abnormalities in patients with early Alzheimer diseaseK L Davis, R C Mohs, D B Marin, et al.
Biological Psychiatry|February 15, 1993
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological studyD P Purohit, M Davidson, D P Perl, et al.
Schizophrenia Research|May 1, 1994
Cortical cholinergic markers in schizophreniaV Haroutunian, M Davidson, P D Kanof, et al.
Neurology|September 4, 2008
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathologyM S Beeri, J Schmeidler, J M Silverman, et al.
International Journal of Alzheimer'S Disease|July 14, 2012
Characterizing cognitive deficits and dementia in an aging urban population in IndiaG Nair, K Van Dyk, U Shah, et al.
Journal of Neurochemistry|February 1, 1995
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficitsL M Bierer, V Haroutunian, S Gabriel, et al.
Archives of Neurology|December 26, 2001
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive declineS Parvathy, P Davies, V Haroutunian, et al.
Acta Neuropathologica|January 1, 1994
Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disordersP R Hof, E A Nimchinsky, V Buée-Scherrer, et al.
Psychiatry Research|December 1, 1993
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptomsL M Bierer, P J Knott, J M Schmeidler, et al.
Neurology|May 10, 2006
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriersM S Beeri, M Rapp, J M Silverman, et al.
Pageof 3